IL10 and chronic myelogenous leukemia, BCR-ABL1 positive: have reported the production of the immunosuppressive IL-10 cytokine, a potent inhibitor of type 1 cytokines, by CML cells cultivated in vitro and have demonstrated that its neutralization by monoclonal antibody considerably enhanced the proliferation of lymphocytes in mixed lymphocyte/tumor cell cultures [38].